Opiate Substitution Treatment

"Opiate Substitution Treatment" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Medical treatment for opioid dependence using a substitute opiate such as METHADONE or BUPRENORPHINE.

Descriptor ID	D058850
MeSH Number(s)	E02.319.620
Concept/Terms	Opiate Substitution Treatment Opiate Substitution Treatment Opiate Substitution Treatments Substitution Treatment, Opiate Substitution Treatments, Opiate Treatment, Opiate Substitution Treatments, Opiate Substitution Opioid Substitution Treatment Opioid Substitution Treatments Substitution Treatment, Opioid Substitution Treatments, Opioid Treatment, Opioid Substitution Treatments, Opioid Substitution Opioid Substitution Therapy Opioid Substitution Therapies Substitution Therapies, Opioid Substitution Therapy, Opioid Therapies, Opioid Substitution Therapy, Opioid Substitution Opiate Replacement Therapy Opiate Replacement Therapies Replacement Therapies, Opiate Replacement Therapy, Opiate Therapies, Opiate Replacement Therapy, Opiate Replacement Opioid Replacement Therapy Opioid Replacement Therapies Replacement Therapies, Opioid Replacement Therapy, Opioid Therapies, Opioid Replacement Therapy, Opioid Replacement

Below are MeSH descriptors whose meaning is more general than "Opiate Substitution Treatment".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Opiate Substitution Treatment [E02.319.620]

Below are MeSH descriptors whose meaning is more specific than "Opiate Substitution Treatment".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Opiate Substitution Treatment" by people in this website by year, and whether "Opiate Substitution Treatment" was a major or minor topic of these publications.

Bar chart showing 71 publications over 13 distinct years, with a maximum of 10 publications in 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2010	1	0	1
2011	1	0	1
2012	4	1	5
2013	2	1	3
2014	4	0	4
2015	4	0	4
2016	2	2	4
2017	3	2	5
2018	6	3	9
2019	3	6	9
2020	5	4	9
2021	1	6	7
2022	0	10	10

Below are the most recent publications written about "Opiate Substitution Treatment" by people in Profiles.

Jawa R, Walley AY, Wilson DJ, Green TC, McKenzie M, Hoskinson R, Bratberg J, Ramsey S, Rich JD, Friedmann PD. Prescribe to Save Lives: Improving Buprenorphine Prescribing Among HIV Clinicians. J Acquir Immune Defic Syndr. 2022 08 15; 90(5):546-552.

View in: PubMed
Ober AJ, Murray-Krezan C, Page K, Friedmann PD, Chan Osilla K, Ryzewicz S, Huerta S, Mazer MW, Leamon I, Messineo G, Watkins KE, Nuckols T, Danovitch I. The Substance Use Treatment and Recovery Team (START) study: protocol for a multi-site randomized controlled trial evaluating an intervention to improve initiation of medication and linkage to post-discharge care for hospitalized patients with opioid use disorder. Addict Sci Clin Pract. 2022 07 28; 17(1):39.

View in: PubMed
Glanz JM, Binswanger IA, Clarke CL, Nguyen AP, Ford MA, Ray GT, Xu S, Hechter RC, Yarborough BJH, Roblin DW, Ahmedani B, Boscarino JA, Andrade SE, Rosa CL, Campbell CI. The association between buprenorphine treatment duration and mortality: a multi-site cohort study of people who discontinued treatment. Addiction. 2023 Jan; 118(1):97-107.

View in: PubMed
Melnick ER, Nath B, Dziura JD, Casey MF, Jeffery MM, Paek H, Soares WE, Hoppe JA, Rajeevan H, Li F, Skains RM, Walter LA, Patel MD, Chari SV, Platts-Mills TF, Hess EP, D'Onofrio G. User centered clinical decision support to implement initiation of buprenorphine for opioid use disorder in the emergency department: EMBED pragmatic cluster randomized controlled trial. BMJ. 2022 06 27; 377:e069271.

View in: PubMed
Stimmel MA, Smelson D, Finlay AK. Moving Beyond the Medication or Psychosocial Treatment Dichotomy to Address the Opioid Epidemic. Psychiatr Serv. 2022 12 01; 73(12):1320-1321.

View in: PubMed
Schoenfeld EM, Westafer LM, Beck SA, Potee BG, Vysetty S, Simon C, Tozloski JM, Girardin AL, Soares WE. "Just give them a choice": Patients' perspectives on starting medications for opioid use disorder in the ED. Acad Emerg Med. 2022 08; 29(8):928-943.

View in: PubMed
Pivovarova E, Evans EA, Stopka TJ, Santelices C, Ferguson WJ, Friedmann PD. Legislatively mandated implementation of medications for opioid use disorders in jails: A qualitative study of clinical, correctional, and jail administrator perspectives. Drug Alcohol Depend. 2022 05 01; 234:109394.

View in: PubMed
Ameral V, Hocking E, Leviyah X, Newberger NG, Timko C, Livingston N. Innovating for real-world care: A systematic review of interventions to improve post-detoxification outcomes for opioid use disorder. Drug Alcohol Depend. 2022 04 01; 233:109379.

View in: PubMed
Evans EA, Pivovarova E, Stopka TJ, Santelices C, Ferguson WJ, Friedmann PD. Uncommon and preventable: Perceptions of diversion of medication for opioid use disorder in jail. J Subst Abuse Treat. 2022 07; 138:108746.

View in: PubMed
Evans EA, Wilson D, Friedmann PD. Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder. Drug Alcohol Depend. 2022 02 01; 231:109254.

View in: PubMed

People

Explore

Similar Concepts

Top Journals